Hjertemagnyl 150mg / 75mg – Prophylaxis of Coronary Thrombosis, Infarction, Stroke

Hjertemagnyl: A Reliable Solution for Preventing Thrombosis

Hjertemagnyl serves as a key preventive measure against thrombosis in patients with ischemic heart disease, myocardial infarction, ischemic stroke, or transient ischemic attack (TIA). By inhibiting platelet aggregation, it effectively reduces the risk of clot formation. This article delves into its composition, provides recommended usage guidelines, and highlights crucial considerations.

Hjertemagnyl Composition:

The active substance in medication is acetylsalicylic acid, with each film-coated tablet containing 150 mg. The tablet core consists of magnesium hydroxide, potato starch, magnesium stearate, maize starch, and microcrystalline cellulose. The film coating includes hypromellose, propylene glycol, and talc.

Recommended Hjertemagnyl Usage:

For safe and effective use, follow the instructions provided by your healthcare professional or refer to the accompanying leaflet. The recommended daily dose for adults is one tablet (75 to 150 mg). If adjustments below 150 mg are necessary, use tablets of different strengths as directed by your healthcare provider. If you have any concerns or questions, consult your doctor.

Hjertemagnyl  Administration:

To facilitate administration, swallow Hjertemagnyl tablets whole with water. In case of difficulty swallowing, you may divide the tablet into smaller parts or chew it before swallowing.

Considerations for Specific Groups:

• Children and Adolescents: it is not suitable for individuals under 16 years old or those aged 16 to 18 years.
• Elderly Patients: If you are an elderly patient, consult your doctor before using Hjertemagnyl.
• Patients with Renal Impairment: Mild to moderate renal impairment does not require dose adjustment, but exercise caution. Avoid it in cases of severe renal impairment.
• Patients with Hepatic Impairment: Mild to moderate hepatic impairment does not require dose adjustment, but exercise caution. Avoid Hjertemagnyl in cases of severe hepatic impairment.

Important Warnings:

• Adhere to the recommended daily dose and avoid exceeding it.
• If you are pregnant, breastfeeding, or have underlying medical conditions, consult your doctor before using Hjertemagnyl.
• The effectiveness of Hjertemagnyl may be influenced by the consumption of spicy foods, products containing mint, and the use of stimulating substances. Use caution when using such substances alongside Hjertemagnyl.
• Temporary exacerbation of symptoms may occur with homeopathic medicines. If aggravation persists, discontinue the use and seek guidance from your doctor or pharmacist.

Conclusion:

this medication stands as an effective preventive measure against thrombosis in various cardiovascular conditions. Understanding its composition, following the recommended usage guidelines, and considering specific factors for different patient groups contribute to the safe and effective use of this medication. For personalized advice and guidance, consult your healthcare professional.